UNSPSC 51203002: Lobenzarit disodium

This classification denotes an antioxidant with the molecular formula C14H8ClNO4.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7Z9SP74BXF, chemically known as benzoic acid, 2-((2-carboxyphenyl)amino)-4-chloro-, disodium salt, but more generally known as lobenzarit disodium, which bears US NIH Compound Identifier 47462. European Medicines Agency schedules lobenzarit disodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08543MIG.

Most nations, for tariff purposes, schedule lobenzarit disodium under HS 29224995. SMILES: C1CCC(C(C1)C(=O)[O-])NC2CC(CCC2C(=O)[O-])CL.[NA+].[NA+].

UNSPSC 51203002 Lobenzarit disodium is a Commodity code that nominally identifies a single pharmaceutical product, but recent state and local solicitations tagged with this code show little alignment with the product itself. The recent opportunities instead span naloxone procurement, direct-to-manufacturer prescription programs, medical and first aid supplies for fire rescue operations, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local participants across multiple states including Oregon). The mix reflects both single-jurisdiction buys and cooperative purchasing vehicles that serve multiple government entities.

Activity is geographically dispersed across Florida, Texas, Minnesota, and Oregon in the recent record, with no single state dominating. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (posted June 30, 2026, due July 26, 2023), the City of Tampa's sealed-bid solicitation for medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000.00 (posted March 25, 2026, due March 13, 2026), the Texas HHS Commission's Request for Information on a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program (posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 proposal deadline. The code shows limited relevance to the nominal product definition and warrants scrutiny of how it is being applied by issuing bodies in practice.